APA (7th ed.) Citation

SA, S., SL, B., W, K., S, L., E, K., M, P., . . . CA, D. (2016). Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth. PLoS pathogens, 12(11), e1005989. https://doi.org/10.1371/journal.ppat.1005989

Chicago Style (17th ed.) Citation

SA, Smith, Burton SL, Kilembe W, Lakhi S, Karita E, Price M, Allen S, Hunter E, and Derdeyn CA. "Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth." PLoS Pathogens 12, no. 11 (2016): e1005989. https://doi.org/10.1371/journal.ppat.1005989.

MLA (9th ed.) Citation

SA, Smith, et al. "Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth." PLoS Pathogens, vol. 12, no. 11, 2016, p. e1005989, https://doi.org/10.1371/journal.ppat.1005989.